Serum ceramides increase the risk of Alzheimer disease
Michelle M. Mielke(Wake Forest University), Michelle C. Carlson(Mayo Clinic), Marilyn Albert(Alzheimer’s Disease Neuroimaging Initiative), Constantine G. Lyketsos(Johns Hopkins University), Eric B. Schneider(Yale University), Greg M. Harris(Veterans Health Administration), Peter V. Rabins(Johns Hopkins University), Karen Bandeen‐Roche(Johns Hopkins University), Linda P. Fried(Unknown), Vijay R. Varma(National Institutes of Health), Veera Vankata Ratnam Bandaru(Mayo Clinic), Sevil Yaşar(Mayo Clinic), Jin Xia(Mayo Clinic), Norman J. Haughey(Tulane University)
Cited by 229
Related Papers
Frailty in Older Adults: Evidence for a Phenotype
|The Journals of Gerontology Series A|2001|24.4k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|2k
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k